NOVEN ADDED TO NASDAQ NEUROINSIGHTS NEUROTECH INDEX |
BackMiami, FL, June 25,
2008 -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) announced today
that it has been added to the NASDAQ® NeuroInsights® Neurotech
Index (NASDAQ: NERV). The Neurotech Index is designed to track the
performance of leading neurotechnology companies listed and actively
traded on one of the three major U.S. stock exchanges.
The Neurotech Index includes companies engaged in researching, developing,
manufacturing and marketing pharmaceuticals, biologics, medical devices
and diagnostics for the brain and nervous system. In addition to meeting
minimum market criteria, the companies included in the index must be
identified by NeuroInsights as significantly involved in the neurotechnology
industry, which includes treatments and diagnostics for disorders like
Alzheimer’s, addiction, anxiety, depression, epilepsy, multiple
sclerosis, obesity, pain, Parkinson’s, schizophrenia, sensory disorders,
sleep disorders, stroke, and traumatic brain injury. Noven’s specialty
pharmaceutical unit, Noven Therapeutics, markets and sells prescription
products for the treatment of major depressive disorder, bipolar disorder
and other psychiatric conditions.
About Noven
Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged
in the research, development, manufacture, marketing and sale of prescription
pharmaceutical products. Noven’s business and operations are focused
in three principal areas – transdermal drug delivery, the Novogyne
joint venture, and its Noven Therapeutics specialty pharmaceutical unit. For additional information, see www.noven.com.
About
NeuroInsights
NeuroInsights is the world’s leading neurotechnology research and
advisory firm. As the neurotechnology market authority, NeuroInsights
helps investors, industry and society understand and profit from the
rapid growth in drugs, devices and diagnostics for the brain and nervous
system. NeuroInsights provides market reports, investment information,
industry events and strategic advisory services to venture funds, startups,
corporations, governments and financial institutions. For more information,
visit www.neuroinsights.com.
About
NASDAQ
NASDAQ is the largest U.S. equities exchange. With approximately 3,200
companies, it lists more companies and, on average, trades more shares
per day than any other U.S. market. It is home to companies that are
leaders across all areas of business including technology, retail, communications,
financial services, transportation, media and biotechnology. NASDAQ is
the primary market for trading NASDAQ-listed stocks as well as a leading
liquidity pool for trading NYSE-listed stocks. For more information about
NASDAQ, visit the NASDAQ Web site at www.nasdaq.com or the NASDAQ Newsroom at www.nasdaq.com/newsroom.
Noven
Contact:
|
Copyright © 2008 Noven Pharmaceuticals, Inc. All rights reserved.